-transparent.png){kind=logo}
Twenty-four patients with acute exacerbations of chronic bronchitis were treated with cefaclor at a dose of 500 mg every 8 hours for 10 days. Studies included volume, appearance and bacteriological examination of sputum, and haematological and virus serology tests. The response to therapy was judged on the reduction in sputum volume or the conversion of its character from purulent to mucoid. Nineteen of 24 patients improved and in 4 of 5 failures, positive serology for influenza virus was found. Growth of Pseudomonas occurred in one sputum. Minor side effects were seen in 3 patients, and no haematological or biochemical abnormalities were found.
Related Publications
L Wernstedt, and
E Berntsson, and
G Thiringer
January 1992,
Postgraduate medical journal,
L Wernstedt, and
E Berntsson, and
G Thiringer
March 1982,
The New Zealand medical journal,
L Wernstedt, and
E Berntsson, and
G Thiringer
January 2002,
Medical science monitor : international medical journal of experimental and clinical research,
L Wernstedt, and
E Berntsson, and
G Thiringer
September 2000,
Seminars in respiratory infections,
L Wernstedt, and
E Berntsson, and
G Thiringer
January 1981,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
L Wernstedt, and
E Berntsson, and
G Thiringer
December 1966,
Physiotherapy,
L Wernstedt, and
E Berntsson, and
G Thiringer
January 1983,
The Journal of antimicrobial chemotherapy,
L Wernstedt, and
E Berntsson, and
G Thiringer
April 1992,
The American journal of medicine,
L Wernstedt, and
E Berntsson, and
G Thiringer
October 1997,
Hospital practice (1995),
L Wernstedt, and
E Berntsson, and
G Thiringer
December 1994,
Postgraduate medicine,
